Impact of Cognitive Rehab and Physical Activity on Cognition in Patients With Metastatic Brain Tumors Undergoing RT

July 11, 2018 updated by: Virginia Commonwealth University

Does Cognitive Rehabilitation and Physical Activity Impact Executive Functioning Following Radiation Therapy for Cerebral Metastases? A Pilot Study

To determine the feasibility of processes and instruments with an overarching purpose to guide the design of a larger study. To determine the feasibility of individuals with metastatic brain tumor(s) to engage in physical activity(PA) and cognitive rehabilitation (CR) as in an outpatient therapy setting.

Study Overview

Detailed Description

Rolling recruitment for the study. Participants will be randomized into one of three treatment arms. All treatment arms will undergo physical & cognitive testing prior to whole-brain radiation therapy (WBRT)/stereotactic radiosurgery (SRS). Arm 3 will receive cognitive rehabilitation intervention sessions prior to, and concurrent with, WBRT/SRS. Approximately 14 days following WBRT/SRS: all arms will undergo physical and cognitive testing, and: Arm 1 will begin physical activity intervention. Arm 2 will begin physical activity intervention and cognitive intervention. Arm 3 will continue with cognitive intervention and begin physical activity intervention. All Arms will undergo physical and cognitive testing approximately 2.5 months post WBRT/SRS.

Study Type

Interventional

Enrollment (Actual)

2

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Virginia
      • Richmond, Virginia, United States, 23298-0037
        • Virginia Commonwealth University/Massey Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • A potential subject must meet all of the following inclusion criteria to be eligible to participate in the study:
  • Ability to understand and the willingness to provide written informed consent
  • 18 years of age and older
  • Diagnosed with one or more metastatic brain tumor(s)
  • Medical treatment plan includes whole-brain radiation therapy and / or sterotactic radiosurgery

Exclusion Criteria:

  • A potential subject who meets any of the following exclusion criteria is ineligible to participate in the study.
  • Diagnosis of dementia or unable to grant their own informed consent
  • Prisoner or patient in custody
  • Patient on psychiatric hold
  • Physically unable to participate in the study
  • The opinion of the treating physician determines it is not medically safe to participate in the study
  • Pre-registration screen of cognition is "severe" or lower.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Arm 1: Physical activity intervention
Undergo baseline testing of physical (lower body strength, endurance) and cognitive (executive functioning) abilities. 14 days (± 2 days) following WBRT/SRS: all arms undergo testing of physical (lower body strength, endurance) and cognitive (executive functioning) abilities. Arm 1: intervention of physical activity begins. 60 days (± 5 days) post testing after WBRT/SRS: all arms undergo final testing of physical (lower body strength, endurance) and cognitive (executive functioning) abilities.
  • Self-exercise: number of steps per day, per fitness tracker; self-report of daily activity.
  • One-to-one intervention: 30 minute sessions with licensed therapist to include warm-up, generalized strengthening, stretching.
Other Names:
  • PA
Active Comparator: Arm 2:Physical activity and cognitive intervention
Undergo baseline testing of physical (lower body strength, endurance) and cognitive (executive functioning) abilities. 14 days (± 2 days) following WBRT/SRS: all arms undergo testing of physical (lower body strength, endurance) and cognitive (executive functioning) abilities. Arm 2: intervention of both cognitive rehabilitation and physical activity begins. 60 days (± 5 days) post testing after WBRT/SRS: all arms undergo final testing of physical (lower body strength, endurance) and cognitive (executive functioning) abilities.
  • Self-exercise: number of steps per day, per fitness tracker; self-report of daily activity.
  • One-to-one intervention: 30 minute sessions with licensed therapist to include warm-up, generalized strengthening, stretching.
Other Names:
  • PA
One-to-one intervention: 45 minutes sessions with licensed therapist to include graded cognitive tasks designed to improve executive functioning with focus on both restorative and compensatory approaches.
Other Names:
  • CR
  • Cognitive retraining
Active Comparator: Arm 3: Cognitive and begin physical activity intervention
Undergo baseline testing of physical (lower body strength, endurance) and cognitive (executive functioning) abilities. Arm 3: Intervention of cognitive rehabilitation begins prior to and is concurrent with WBRT/SRS treatment. 14 days (± 2 days) following WBRT/SRS: all arms undergo testing of physical (lower body strength, endurance) and cognitive (executive functioning) abilities. Arm 3: continue intervention of cognitive rehabilitation; add intervention of physical activity. 60 days (± 5 days) post testing after WBRT/SRS: all arms undergo final testing of physical (lower body strength, endurance) and cognitive (executive functioning) abilities.
  • Self-exercise: number of steps per day, per fitness tracker; self-report of daily activity.
  • One-to-one intervention: 30 minute sessions with licensed therapist to include warm-up, generalized strengthening, stretching.
Other Names:
  • PA
One-to-one intervention: 45 minutes sessions with licensed therapist to include graded cognitive tasks designed to improve executive functioning with focus on both restorative and compensatory approaches.
Other Names:
  • CR
  • Cognitive retraining

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment percentage of eligible subjects.
Time Frame: 18.5 months
Recruitment: success defined as enrollment rate of 19% of eligible subjects.
18.5 months
Retention percentage of participants at end-of-study.
Time Frame: 18.5 months
Retention: success defined as retention rate above 56% at end-of-study.
18.5 months
Non-attendance rates of participants. instructions.
Time Frame: 18.5 months
Participant missed or cancelled therapy sessions less than 15% of time.
18.5 months
Lengths of sessions completed.
Time Frame: 18.5 months
Participant completed full scheduled minutes per session ≥ 80% of time.
18.5 months
Percentage of completion of Physical Activity intervention tasks.
Time Frame: 18.5 months
Participant completed ≥ 80% of PA interventions (required < 20% rest period during or between tasks).
18.5 months
Percentage of Cognitive Therapy intervention tasks.
Time Frame: 18.5 months
Participant completed ≥ 80% of CR interventions (required < 20% rest period during or between tasks).
18.5 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in cognitive abilities.
Time Frame: 18.5 months

Composite score post-CR intervention, minus the composite score at baseline. Scores of zero indicates maintained cognition. Positive scores indicate improved cognition. Negative scores indicate declined cognition. Composite scores derived from the following four standardized tests:

  • The Stroop Color Word Test (SCWT) is a 3-part measure that tests the executive function area of attention.
  • The Trail Making Test (TMT) is a 2-part measure that tests the executive function area of complex attention.
  • The Rey Auditory Verbal Learning Test (AVLT) is a 6-part measure that tests the executive function area of memory.
  • The Clock Drawing Test (CDT) is a single measure that tests the executive function area of visuospatial relationships and praxis.
18.5 months
Change in physical abilities.
Time Frame: 18.5 months

Composite scores post intervention minus scores at baseline. Scores of zero indicate maintained physical abilities. Positive scores indicate improved physical abilities. Negative scores indicate declined physical abilities. Composite scores derived from the following two standardized tests:

  • The Timed Up and Go (TUG) is a single measure that tests mobility, balance, and walking ability.
  • The 30-second Chair Stand Test (30sCST) is a single measure that tests functional lower body strength.
18.5 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Suzanne F. Taylor, PhD, MBA, OTR/L, Virginia Commonwealth University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2017

Primary Completion (Actual)

July 9, 2018

Study Completion (Actual)

July 9, 2018

Study Registration Dates

First Submitted

March 23, 2017

First Submitted That Met QC Criteria

March 23, 2017

First Posted (Actual)

March 30, 2017

Study Record Updates

Last Update Posted (Actual)

July 13, 2018

Last Update Submitted That Met QC Criteria

July 11, 2018

Last Verified

July 1, 2018

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Metastatic Brain Tumor

Clinical Trials on Physical Activity

3
Subscribe